Endoparasitic

Miziziziz · 2022 · $9.99 · Indie · deal grade C

• Estimated net residual revenue: $1.8k to $2.7k per month
• Opportunity: $2.3k per month at x1.00 dormancy
• Estimated lifetime owners: 93.0k
• 94%% positive across 3068 reviews · 36.3 reviews/month

Why it's flagged

• Developer active, last post 3 months ago
• Studio active elsewhere (6 titles tracked), so this one may welcome a partner
• Last build shipped 0 months ago

This case as Markdown · Estimates carry ±30-50%% error per title.